Abstract

Background: Elephants are classified as critically endangered animals by the International Union for Conservation of Species (IUCN). Elephant endotheliotropic herpesvirus (EEHV) poses a large threat to breeding programs of captive Asian elephants by causing fatal haemorrhagic disease. EEHV infection is detected by PCR in samples from both clinically ill and asymptomatic elephants with an active infection, whereas latent carriers can be distinguished exclusively via serological assays. To date, identification of latent carriers has been challenging, since there are no serological assays capable of detecting seropositive elephants. Results: Here we describe a novel ELISA that specifically detects EEHV antibodies circulating in Asian elephant plasma/serum. Approximately 80 % of PCR positive elephants display EEHV-specific antibodies. Monitoring three Asian elephant herds from European zoos revealed that the serostatus of elephants within a herd varied from nondetectable to high titers. The antibody titers showed typical herpes-like rise-and-fall patterns in time which occur in all seropositive animals in the herd more or less simultaneously. Conclusions: This study shows that the developed ELISA is suitable to detect antibodies specific to EEHV. It allows study of EEHV seroprevalence in Asian elephants. Results confirm that EEHV prevalence among Asian elephants (whether captive-born or wild-caught) is high.

Highlights

  • Petra B. van den Doel1, Víctor Rodríguez Prieto3, Sarah E. van Rossum-Fikkert4, Willem Schaftenaar5, Erin Latimer6, Lauren Howard7, Sarah Chapman8, Nic Masters9, Albert D

  • Full list of author information is available at the end of the article

  • Research which is freely available for redistribution

Read more

Summary

Introduction

Petra B. van den Doel1, Víctor Rodríguez Prieto3, Sarah E. van Rossum-Fikkert4, Willem Schaftenaar5, Erin Latimer6, Lauren Howard7, Sarah Chapman8, Nic Masters9, Albert D. Molewaterplein 50, Rotterdam 3015, GE, The Netherlands.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.